Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Healthcare-associated infections in Australia: time for national surveillance

Russo PL, Cheng AC, Richards M, Graves N, Hall L

(2015), Aust Health Rev, 39(1), 37-43

Differences in identifying healthcare associated infections using clinical vignettes and the influence of respondent characteristics: a cross-sectional survey of Australian infection prevention staff

Russo PL, Barnett AG, Cheng AC, Richards M, Graves N, Hall L

(2015), Antimicrob Resist Infect Control, 4, 29

Direct hospital cost determinants following hip and knee arthroplasty

Peel TN, Cheng AC, Liew D, Buising KL, Lisik J, Carroll KA, Choong PF, Dowsey MM

(2015), Arthritis Care Res, 67(6), 782-90

Hepatitis C virus reinfection and spontaneous clearance of reinfection--the InC3 Study

Sacks-Davis R, Grebely J, Dore GJ, Osburn W, Cox AL, Rice TM, Spelman T, Bruneau J, Prins M, Kim AY, McGovern BH, Shoukry NH, Schinkel J, Allen TM, Morris M, Hajarizadeh B, Maher L, Lloyd AR, Page K, Hellard M; InC3 study group

(2015), J Infect Dis, 212(9), 1407-19

Paying the price in an era of HIV treatment as prevention: a retrospective study of the cost burden of HIV treatment for people living with HIV in Victoria, Australia

Wilkinson AL, McMahon J, Cheah YS, Bradshaw CS, El-Hayek C, Stoové M

(2015), Sex Health, 12(1), 34-8

CD14(hi)CD16+ monocytes phagocytose antibody-opsonised Plasmodium falciparum infected erythrocytes more efficiently than other monocyte subsets, and require CD16 and complement to do so

Zhou J, Feng G, Beeson J, Hogarth PM, Rogerson SJ, Yan Y, Jaworowski A

(2015), BMC Med, 13, 154

Effect of ipilimumab on the HIV reservoir in an HIV-infected individual with metastatic melanoma

Wightman F, Solomon A, Kumar SS, Urriola N, Gallagher K, Hiener B, Palmer S, Mcneil C, Garsia R, Lewin SR

(2015), AIDS, 29(4), 504-6

In vitro pharmacodynamics of fosfomycin against clinical isolates of Pseudomonas aeruginosa

Walsh CC, McIntosh MP, Peleg AY, Kirkpatrick CM, Bergen PJ

(2015), J Antimicrob Chemother, 70(11), 3042-50

Management guidelines for non-AIDS morbidity result in increased screening but no change in primary prevention implementation

Trevillyan JM, Dart A, Topliss DJ, Walker RG, Whiting SE, Hoy JF

(2015), AIDS, 29(6), 748-50

Differentiation of Acinetobacter genomic species 13BJ/14TU from Acinetobacter haemolyticus by use of matrix-sssisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS)

Toh BE, Zowawi HM, Krizova L, Paterson DL, Kamolvit W, Peleg AY, Sidjabat H, Nemec A, Pflüger V, Huber CA

(2015), J Clin Microbiol, 53(10), 3384-6

Silent mutations at codons 65 and 66 in reverse transcriptase alleviate indel formation and restore fitness in subtype B HIV-1 containing D67N and K70R drug resistance mutations

Telwatte S, Hearps AC, Johnson A, Latham CF, Moore K, Agius P, Tachedjian M, Sonza S, Sluis-Cremer N, Harrigan PR, Tachedjian G

(2015), Nucleic Acids Res, 43(6), 3256-71

Plasma interleukin-18 levels are a biomarker of innate immune responses that predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome

Tan HY, Yong YK, Andrade BB, Shankar EM, Ponnampalavanar S, Omar SF, Narendran G, Kamarulzaman A, Swaminathan S, Sereti I, Crowe SM, French MA

(2015), AIDS, 29(4), 421-31

Impact of antiretroviral therapy (ART) timing on chronic immune activation/inflammation and end-organ damage

Rajasuriar R, Wright E, Lewin SR

(2015), Curr Opin HIV AIDS, 10(1), 35-42

Glucose metabolism regulates T cell activation, differentiation, and functions

Palmer CS, Ostrowski M, Balderson B, Christian N, Crowe SM

(2015), Front Immunol, 6, 1

Experiences and expectations of participants completing an HIV cure focused clinical trial

McMahon JH, Elliott JH, Roney J, Hagenauer M, Lewin SR

(2015), AIDS, 29(2), 248-50

Managing Pseudomonas aeruginosa respiratory infections in cystic fibrosis

Langan KM, Kotsimbos T, Peleg AY

(2015), Curr Opin Infect Dis, 28(6), 547-56

Bone disease in HIV: recommendations for screening and management in the older patient

Hoy J

(2015), Drugs Aging, 32(7), 549-58

Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial

Harris PN, Peleg AY, Iredell J, Ingram PR, Miyakis S, Stewardson AJ, Rogers BA, McBryde ES, Roberts JA, Lipman J, Athan E, Paul SK, Baker P, Harris-Brown T, Paterson DL

(2015), Trials, 16, 24

Factors influencing antiretroviral adherence and virological outcomes in people living with HIV in the highlands of Papua New Guinea

Gare J, Kelly-Hanku A, Ryan CE, David M, Kaima P, Imara U, Lote N, Crowe SM, Hearps AC

(2015), PLoS One, 10(8), e0134918

The influence of bacterial interaction on the virulence of Cryptococcus neoformans

Dhamgaye S, Murray GL, Peleg AY

(2015), Virulence, 6(7), 677-8

30 31 32 33 34